Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Environmental Data and Survival Data of Deinococcus aetherius from the Exposure Facility of the Japan Experimental Module of the International Space Station Obtained by the Tanpopo Mission.

Yamagishi A, Kawaguchi Y, Hashimoto H, Yano H, Imai E, Kodaira S, Uchihori Y, Nakagawa K.

Astrobiology. 2018 Oct 5. doi: 10.1089/ast.2017.1751. [Epub ahead of print]

PMID:
30289276
2.

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Tanaka T, Nangaku M, Imai E, Tsubakihara Y, Kamai M, Wada M, Asada S, Akizawa T.

Clin Exp Nephrol. 2018 Sep 4. doi: 10.1007/s10157-018-1632-9. [Epub ahead of print]

PMID:
30182223
3.

Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.

Maruta Y, Hasegawa T, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A.

Clin Exp Nephrol. 2018 Aug 24. doi: 10.1007/s10157-018-1631-x. [Epub ahead of print]

PMID:
30168046
4.

Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2018 Aug 9. doi: 10.1007/s10157-018-1624-9. [Epub ahead of print]

PMID:
30094596
5.

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2018 Jun 27. doi: 10.1007/s10157-018-1605-z. [Epub ahead of print] Erratum in: Clin Exp Nephrol. 2018 Aug 9;:.

PMID:
29951723
6.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Apr 20. doi: 10.1007/s10157-018-1579-x. [Epub ahead of print]

PMID:
29679356
7.
8.

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.

Kawamura T, Usui J, Kaneko S, Tsunoda R, Imai E, Kai H, Morito N, Saito C, Nagata M, Yamagata K.

BMC Nephrol. 2017 Nov 25;18(1):337. doi: 10.1186/s12882-017-0754-8.

9.

An objective evaluation of nocturnal cough count and cough pattern in children with psychogenic cough.

Imai E, Hirai K, Mikami Y, Nukaga M, Enseki M, Tabata H, Kato M, Mochizuki H.

Respir Investig. 2017 Nov;55(6):334-337. doi: 10.1016/j.resinv.2017.08.008. Epub 2017 Oct 21. Review.

PMID:
29153413
10.

Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2017 Dec;21(6):1146. doi: 10.1007/s10157-017-1466-x. No abstract available.

PMID:
28889397
11.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
12.

A lung sound analysis in a child thought to have cough variant asthma: A case report.

Imai E, Enseki M, Nukaga M, Tabata H, Hirai K, Kato M, Mochizuki H.

Allergol Int. 2018 Jan;67(1):150-152. doi: 10.1016/j.alit.2017.06.004. Epub 2017 Jun 30. No abstract available.

13.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

14.
15.

Different Psychosocial Factors Are Associated With Different Intention and Self-Efficacy Toward Eating Breakfast Among Japanese Breakfast Skippers.

Nakade M, Tsubota-Utsugi M, Imai E, Tsuboyama-Kasaoka N, Nishi N, Takimoto H.

Asia Pac J Public Health. 2017 Mar;29(2):102-113. doi: 10.1177/1010539517691092. Epub 2017 Feb 15.

PMID:
28201941
16.

Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.

Sakata F, Ito Y, Mizuno M, Sawai A, Suzuki Y, Tomita T, Tawada M, Tanaka A, Hirayama A, Sagara A, Wada T, Maruyama S, Soga T, Matsuo S, Imai E, Takei Y.

Lab Invest. 2017 Apr;97(4):432-446. doi: 10.1038/labinvest.2017.4. Epub 2017 Feb 6.

17.
18.

Cardiovascular events and death in Japanese patients with chronic kidney disease.

Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.

Kidney Int. 2017 Jan;91(1):227-234. doi: 10.1016/j.kint.2016.09.015. Epub 2016 Nov 22.

19.

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.

Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.

Clin Exp Nephrol. 2017 Dec;21(6):961-970. doi: 10.1007/s10157-016-1340-2. Epub 2016 Oct 25.

20.

Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.

Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, Kaneko S, Kono E, Sakai Y, Sakai N, Sakamaki Y, Taniguchi Y, Nakai K, Nishiwaki H, Hirata S, Yamaya H, Tsuruoka S, Terada Y, Yokoyama H, Wada T, Narita I.

Clin Exp Nephrol. 2016 Dec;20(6):827-831. Review. No abstract available.

21.

The physical examination content of the Japanese National Health and Nutrition Survey: temporal changes.

Tanaka H, Imai S, Nakade M, Imai E, Takimoto H.

Asia Pac J Clin Nutr. 2016 Dec;25(4):898-910. doi: 10.6133/apjcn.092015.34.

22.

Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.

Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, Imai E, Coresh J, Hishida A.

Kidney Int. 2016 Nov;90(5):1109-1114. doi: 10.1016/j.kint.2016.08.003. Epub 2016 Sep 22.

PMID:
27666758
23.

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.

Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A; Chronic Kidney Disease Japan Cohort Study Group.

Clin Exp Nephrol. 2017 Jun;21(3):446-456. doi: 10.1007/s10157-016-1309-1. Epub 2016 Jul 13.

24.

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis.

Imai E, Kaneko S, Mori T, Okado T, Uchida S, Tsukamoto Y.

Clin Kidney J. 2016 Jun;9(3):424-8. doi: 10.1093/ckj/sfw008. Epub 2016 Mar 24. Erratum in: Clin Kidney J. 2016 Dec;9(6):871.

25.

Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.

Tawada M, Ito Y, Hamada C, Honda K, Mizuno M, Suzuki Y, Sakata F, Terabayashi T, Matsukawa Y, Maruyama S, Imai E, Matsuo S, Takei Y.

PLoS One. 2016 Apr 27;11(4):e0154644. doi: 10.1371/journal.pone.0154644. eCollection 2016.

26.

In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.

Serino G, Pesce F, Sallustio F, De Palma G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Schena FP.

Kidney Int. 2016 Mar;89(3):683-92.

PMID:
26581012
27.

Is the new GFR equation using inulin clearance a more accurate method for Asian patients?

Kim BS, Lee YK, Choi HY, Choi SO, Shin SK, Ha SK, Lee KW, Kim YW, Kim YL, Yasuda Y, Imai E, Horio M, Tomino Y, Matsuo S, Lee HY.

Clin Nephrol. 2015 Dec;84(6):331-8. doi: 10.5414/CN108496.

PMID:
26558368
28.

A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.

Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T.

Nephron Extra. 2015 Aug 29;5(2):58-66. doi: 10.1159/000437338. eCollection 2015 May-Aug.

29.

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.

Kitamura M, Akamatsu M, Kawanami M, Furuichi Y, Fujii T, Mori M, Kunimatsu K, Shimauchi H, Ogata Y, Yamamoto M, Nakagawa T, Sato S, Ito K, Ogasawara T, Izumi Y, Gomi K, Yamazaki K, Yoshie H, Fukuda M, Noguchi T, Takashiba S, Kurihara H, Nagata T, Hamachi T, Maeda K, Yokota M, Sakagami R, Hara Y, Noguchi K, Furuuchi T, Sasano T, Imai E, Ohmae M, Koizumi H, Watanuki M, Murakami S.

J Bone Miner Res. 2016 Apr;31(4):806-14. doi: 10.1002/jbmr.2738. Epub 2015 Dec 6.

30.

Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality.

Sumiyoshi M, Masuda N, Tanuma N, Ogoh H, Imai E, Otsuka M, Hayakawa N, Ohno K, Matsui Y, Hara K, Gotoh R, Suzuki M, Rai S, Tanaka H, Matsumura I, Shima H, Watanabe T.

FEBS Lett. 2015 Sep 14;589(19 Pt B):2754-62. doi: 10.1016/j.febslet.2015.07.050. Epub 2015 Aug 18.

31.

Genome-wide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population.

Saka S, Hirawa N, Oka A, Yatsu K, Hirukawa T, Yamamoto R, Matsusaka T, Imai E, Narita I, Endoh M, Ichikawa I, Umemura S, Inoko H.

J Hum Genet. 2015 Oct;60(10):573-80. doi: 10.1038/jhg.2015.88. Epub 2015 Jul 23.

PMID:
26202575
32.

Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).

Imai E, Ito S, Haneda M, Harada A, Kobayashi F, Yamasaki T, Makino H, Chan JC.

Nephrol Dial Transplant. 2016 Mar;31(3):447-54. doi: 10.1093/ndt/gfv272. Epub 2015 Jul 6.

33.

Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.

Terabayashi T, Ito Y, Mizuno M, Suzuki Y, Kinashi H, Sakata F, Tomita T, Iguchi D, Tawada M, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y.

Lab Invest. 2015 Sep;95(9):1029-43. doi: 10.1038/labinvest.2015.87. Epub 2015 Jun 29.

34.

Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).

Imai E, Maruyama S, Nangaku M, Hirakata H, Hayashi T, Narita I, Kono H, Nakatani E, Morita S, Tsubakihara Y, Akizawa T.

Clin Exp Nephrol. 2016 Feb;20(1):71-6. doi: 10.1007/s10157-015-1133-z. Epub 2015 Jun 17.

PMID:
26081567
35.

A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine.

Katsuma A, Shibata M, Katsuki T, Imai E, Tada M, Hinoshita F.

CEN Case Rep. 2015 May;4(1):76-80. doi: 10.1007/s13730-014-0143-0. Epub 2014 Aug 29.

36.

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S.

Clin Exp Nephrol. 2015 Dec;19(6):1098-106. doi: 10.1007/s10157-015-1106-2. Epub 2015 Mar 21.

37.

Silica aerogel for capturing intact interplanetary dust particles for the Tanpopo experiment.

Tabata M, Yano H, Kawai H, Imai E, Kawaguchi Y, Hashimoto H, Yamagishi A.

Orig Life Evol Biosph. 2015 Jun;45(1-2):225-9. doi: 10.1007/s11084-015-9423-8. Epub 2015 Mar 21.

PMID:
25794831
38.

Difficulty with cuff deflation of reinforced tracheal tube caused by inflation line occlusion with silk thread ligation and fixation.

Gotoh S, Sugiyama D, Imai E, Kawamata M.

BMJ Case Rep. 2015 Mar 5;2015. pii: bcr2014207933. doi: 10.1136/bcr-2014-207933.

39.

Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Hayashi N, Akiyama S, Okuyama H, Matsui Y, Adachi H, Yamaya H, Maruyama S, Imai E, Matsuo S, Yokoyama H.

Clin Exp Nephrol. 2015 Oct;19(5):797-803. doi: 10.1007/s10157-014-1064-0. Epub 2014 Dec 10.

PMID:
25492250
40.

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.

Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S.

Clin Exp Nephrol. 2015 Aug;19(4):653-60. doi: 10.1007/s10157-014-1054-2. Epub 2014 Nov 21.

41.

Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.

Sato Y, Sato W, Maruyama S, Wilcox CS, Falck JR, Masuda T, Kosugi T, Kojima H, Maeda K, Furuhashi K, Ando M, Imai E, Matsuo S, Kadomatsu K.

J Am Soc Nephrol. 2015 Aug;26(8):1806-15. doi: 10.1681/ASN.2013121259. Epub 2014 Nov 5.

42.

Effects of serum albumin and glycated albumin levels on performance of the Japanese GFR equation based on serum cystatin C.

Horio M, Imai E, Yasuda Y, Watanabe T, Yokoyama H, Makino H, Matsuo S.

Clin Exp Nephrol. 2015 Aug;19(4):626-30. doi: 10.1007/s10157-014-1038-2. Epub 2014 Oct 4.

PMID:
25281008
43.

Fluorescence imaging of microbe-containing particles shot from a two-stage Light-gas gun into an aerogel.

Kawaguchi Y, Sugino T, Tabata M, Okudaira K, Imai E, Yano H, Hasegawa S, Hashimoto H, Yabuta H, Kobayashi K, Kawai H, Mita H, Yokobori S, Yamagishi A.

Orig Life Evol Biosph. 2014 Feb;44(1):43-60. doi: 10.1007/s11084-014-9361-x. Epub 2014 Aug 3.

PMID:
25086872
44.

Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.

Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T.

Clin Exp Nephrol. 2015 Jun;19(3):379-86. doi: 10.1007/s10157-014-0996-8. Epub 2014 Jun 17.

PMID:
24934117
45.

Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine.

Horio M, Imai E, Yasuda Y, Watanabe T, Yokoyama H, Makino H, Matsuo S.

Clin Exp Nephrol. 2015 Apr;19(2):284-92. doi: 10.1007/s10157-014-0988-8. Epub 2014 Jun 7.

PMID:
24907068
46.

Taming the chronic kidney disease epidemic: a global view of surveillance efforts.

Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group, O'Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S.

Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.

47.

Prevalence and incidence of chronic kidney disease stage G5 in Japan.

Yamagata K, Yagisawa T, Nakai S, Nakayama M, Imai E, Hattori M, Iseki K, Akiba T.

Clin Exp Nephrol. 2015 Feb;19(1):54-64. doi: 10.1007/s10157-014-0978-x. Epub 2014 May 13. Review.

PMID:
24821288
48.

CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy.

Iwatani H, Nagasawa Y, Yamamoto R, Iio K, Mizui M, Horii A, Kitahara T, Inohara H, Kumanogoh A, Imai E, Rakugi H, Isaka Y.

Clin Exp Nephrol. 2015 Apr;19(2):216-24. doi: 10.1007/s10157-014-0968-z. Epub 2014 May 6.

PMID:
24798970
49.

Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit.

Sueta S, Kondo M, Matsubara T, Yasuhara Y, Akiyama S, Imai E, Amaike H, Tagawa M.

CEN Case Rep. 2014 May;3(1):18-23. doi: 10.1007/s13730-013-0077-y. Epub 2013 May 3.

50.

[Effectiveness of mirtazapine for digestive symptoms in palliative care - retrospective study of 50 cases].

Shibahara H, Uematsu N, Imai E, Tokura Y, Nishimura D.

Gan To Kagaku Ryoho. 2014 Mar;41(3):329-33. Japanese.

PMID:
24743278

Supplemental Content

Support Center